Choose language / Korean

Join Telegram

Mirum Pharmaceuticals (MIRM) achieves successive clinical successes in rare liver diseases…revenue upgraded to $680 million
Bull/Bear Index 45.7/100
crypto BULL 45/10 TokenPost · 1h ago

Mirum Pharmaceuticals (MIRM) achieves successive clinical successes in rare liver diseases…revenue upgraded to $680 million

Mirum Pharmaceuticals (MIRM) is gaining market attention by successively disclosing significant clinical progress in rare liver disease treatments, while also pursuing performance growth, fundraising, and pipeline expansion strategies to strengthen long-term growth drivers.

Catch the next bull catalyst

Telegram alerts when our AI scores a story 8+/10 (~1-3 per day, no spam). Verified 30d hit rate 50.1%.

Join Telegram channel

📡 Tomorrow's Watch

Related news


BEAR 65/10

A Strategy CEO indicates a potential sale of Bitcoin to shift towards shareholder value.

#crypto

45/10

Bitcoin's CME futures market experienced its first gap-free Monday, challenging the validity of a popular 'gap-filling' trading signal.

#crypto

65/10 +1

Bitcoin preps 3% May downside, but US PMI data may boost BTC price  MSN

#crypto

BULL 65/10 +1

Adam Back highlights Bitcoin's 200-week moving average as a structural bull signal, suggesting a positive long-term outlook.

#crypto

BULL 75/10 +1

Adam Back Flags Bitcoin’s 200-Week Average as a Structural Bull Signal  BeInCrypto

#crypto

BULL 55/10

Matt Cole projects that digital credit could reach $3 trillion, offering less volatility than Bitcoin and appealing to risk-averse investors, indicating a significant growth area within the crypto market.

#crypto